Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04090190 · ClinicalTrials.gov registry record · Phase 4
Inflammation in Women With Urgency Urinary Incontinence Treated With Anticholinergics
A Phase 4 study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
NCT04090190 is a Phase 4 study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 20 participants.
The verdict
NCT04090190, a Phase 4 study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
Study Summary
Urinary incontinence (UI) is a very common condition affecting women of all ages. The objective of this pilot study is to better understand the urinary microbiome and associated inflammatory markers in blood and urine in women with urgency UI. The study will assess how inflammation may affect response to standard of care anticholinergic medication treatment for urgency urinary incontinence.
Interventions
- DRUG Oxybutynin, Solifenacin, Tolterodine, Trospium, or Fesoterodine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2019-10-30 |
| Est. Completion | 2021-10-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04090190
The ClinicalTrials.gov registry entry for NCT04090190 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Oxybutynin, Solifenacin, Tolterodine, Trospium, or Fesoterodine is the first listed.
NCT04090190 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04090190 about?
NCT04090190 is a clinical study titled "Inflammation in Women With Urgency Urinary Incontinence Treated With Anticholinergics". Urinary incontinence (UI) is a very common condition affecting women of all ages. The objective of this pilot study is to better understand the urinary microbiome and associated inflammatory markers in blood and urine in women with urgency UI. The study will assess how inflammation may affect respon...
What is the current status of trial NCT04090190?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2019-10-30. Estimated completion is 2021-10-31.
What interventions are being tested in trial NCT04090190?
The interventions under investigation include: Oxybutynin, Solifenacin, Tolterodine, Trospium, or Fesoterodine (DRUG).
Who is sponsoring clinical trial NCT04090190?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.